Bupikomid

Bupikomid
Nazivi
	IUPAC naziv 5-Butil-2-piridinkarboksamid
	Drugi nazivi Sch-10595; Fusaramide
Identifikacija
CAS broj	22632-06-0 ;
3D model (Jmol)	interaktivna slika;
ChemSpider	29167;
ECHA InfoCard	100.041.024
PubChem C ID	31447;
UNII	0X3H76N0HY;
	SMILES O=C(c1ncc(cc1)CCCC)N; ; ; ; ; ;
Svojstva
Hemijska formula	C10H14N2O
Molarna masa	178,24 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Bupikomid je hemijsko jedinjenje koje je razvilo i proizvodi preduzeće Lanospharma Laboratories Company, Ltd. Ono se eksperimentalno koristi kao beta blokator i kao jak vazodilatator. Nuspojave bupikomida su redukovani sistolni, dijastolni i srednji arterijski pritisak.^[4]^[5]

Reference[уреди | уреди извор]

^ Bupicomide, Chemical Book
^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED (1976). „Systemic and renal hemodynamic effects of bupicomide: A new vasodilator”. American heart journal. 92 (3): 335—9. PMID 782220.
^ Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL (1975). „Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine”. Clinical pharmacology and therapeutics. 18 (2): 145—53. PMID 1097150.

Spoljašnje veze[уреди | уреди извор]

[1] Bupicomide, Chemical Book

[2] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

[3] Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.

[4] Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED (1976). „Systemic and renal hemodynamic effects of bupicomide: A new vasodilator”. American heart journal. 92 (3): 335—9. PMID 782220.

[5] Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL (1975). „Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine”. Clinical pharmacology and therapeutics. 18 (2): 145—53. PMID 1097150.

[1]

[2]

[3]

[4]

[5]